Erin Michelle Parry, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Large B-Cell, Diffuse | 10 | 2025 | 1437 | 2.310 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 13 | 2024 | 1642 | 2.020 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2023 | 1375 | 0.650 |
Why?
|
Germ-Line Mutation | 2 | 2017 | 1885 | 0.520 |
Why?
|
Telomere | 6 | 2016 | 944 | 0.500 |
Why?
|
Dyskeratosis Congenita | 4 | 2013 | 70 | 0.500 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2023 | 2846 | 0.460 |
Why?
|
Pulmonary Fibrosis | 3 | 2016 | 506 | 0.450 |
Why?
|
Telomerase | 5 | 2016 | 751 | 0.420 |
Why?
|
DNA Repair | 1 | 2017 | 2050 | 0.300 |
Why?
|
Immunotherapy, Adoptive | 2 | 2025 | 1512 | 0.230 |
Why?
|
Antigens, CD19 | 2 | 2025 | 446 | 0.230 |
Why?
|
Hodgkin Disease | 2 | 2021 | 1384 | 0.220 |
Why?
|
Cell Cycle Proteins | 2 | 2013 | 3445 | 0.210 |
Why?
|
Sulfonamides | 2 | 2024 | 1982 | 0.210 |
Why?
|
Nuclear Proteins | 2 | 2013 | 5804 | 0.170 |
Why?
|
Allergy and Immunology | 1 | 2021 | 175 | 0.170 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6395 | 0.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2023 | 5717 | 0.170 |
Why?
|
Lymphoma, Follicular | 1 | 2023 | 460 | 0.160 |
Why?
|
Mercury | 2 | 2012 | 289 | 0.150 |
Why?
|
Biological Products | 1 | 2025 | 948 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11878 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2023 | 3611 | 0.120 |
Why?
|
RNA | 2 | 2016 | 2720 | 0.110 |
Why?
|
Lymphoma | 1 | 2023 | 1898 | 0.110 |
Why?
|
Emphysema | 1 | 2016 | 236 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 3 | 2016 | 18065 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9419 | 0.100 |
Why?
|
Trout | 1 | 2012 | 20 | 0.100 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13586 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4648 | 0.100 |
Why?
|
Doxorubicin | 3 | 2024 | 2234 | 0.100 |
Why?
|
Humans | 26 | 2025 | 768166 | 0.090 |
Why?
|
Immunotherapy | 2 | 2023 | 4755 | 0.090 |
Why?
|
Vincristine | 2 | 2024 | 1040 | 0.090 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2011 | 96 | 0.090 |
Why?
|
Genome, Human | 1 | 2023 | 4446 | 0.090 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2011 | 183 | 0.080 |
Why?
|
Smoke | 1 | 2011 | 242 | 0.080 |
Why?
|
Heterozygote | 2 | 2013 | 2798 | 0.080 |
Why?
|
Bone Marrow Diseases | 1 | 2011 | 234 | 0.080 |
Why?
|
Anemia, Aplastic | 1 | 2011 | 231 | 0.080 |
Why?
|
X Chromosome Inactivation | 1 | 2011 | 229 | 0.080 |
Why?
|
Aeromonas salmonicida | 1 | 2008 | 5 | 0.080 |
Why?
|
R Factors | 1 | 2008 | 35 | 0.080 |
Why?
|
Conjugation, Genetic | 1 | 2008 | 116 | 0.070 |
Why?
|
B-Lymphocytes | 4 | 2024 | 4793 | 0.070 |
Why?
|
Transplantation, Autologous | 2 | 2023 | 2120 | 0.070 |
Why?
|
Ankyrins | 1 | 2007 | 123 | 0.070 |
Why?
|
Cyclophosphamide | 2 | 2024 | 2227 | 0.070 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 1 | 2007 | 150 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2023 | 11928 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2012 | 840 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3463 | 0.060 |
Why?
|
Pulmonary Emphysema | 1 | 2011 | 689 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2025 | 59629 | 0.060 |
Why?
|
Genetic Linkage | 1 | 2011 | 2342 | 0.060 |
Why?
|
Drug Resistance, Bacterial | 1 | 2012 | 1063 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2025 | 81762 | 0.060 |
Why?
|
Mice | 7 | 2023 | 82029 | 0.060 |
Why?
|
Phenotype | 2 | 2013 | 16726 | 0.060 |
Why?
|
Age of Onset | 1 | 2011 | 3347 | 0.060 |
Why?
|
Insulin-Secreting Cells | 1 | 2011 | 899 | 0.050 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2008 | 591 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4598 | 0.050 |
Why?
|
Pedigree | 1 | 2011 | 4539 | 0.050 |
Why?
|
Mutation | 4 | 2021 | 30238 | 0.050 |
Why?
|
Switzerland | 1 | 2023 | 323 | 0.050 |
Why?
|
Middle Aged | 8 | 2025 | 223492 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2012 | 7477 | 0.050 |
Why?
|
Bacteria | 1 | 2012 | 2216 | 0.050 |
Why?
|
Animals | 9 | 2023 | 169246 | 0.050 |
Why?
|
Bleomycin | 1 | 2021 | 492 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13676 | 0.040 |
Why?
|
Etoposide | 1 | 2022 | 639 | 0.040 |
Why?
|
Male | 10 | 2025 | 364719 | 0.040 |
Why?
|
Vinblastine | 1 | 2021 | 487 | 0.040 |
Why?
|
Aged | 6 | 2025 | 171504 | 0.040 |
Why?
|
Dacarbazine | 1 | 2021 | 552 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2023 | 1015 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2023 | 812 | 0.040 |
Why?
|
Clone Cells | 1 | 2021 | 1670 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2024 | 3671 | 0.040 |
Why?
|
Erythrocytes | 1 | 2007 | 2418 | 0.040 |
Why?
|
Adult | 5 | 2025 | 223646 | 0.040 |
Why?
|
Female | 9 | 2025 | 397192 | 0.030 |
Why?
|
Prednisone | 1 | 2022 | 1567 | 0.030 |
Why?
|
Neutropenia | 1 | 2022 | 892 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1854 | 0.030 |
Why?
|
Adenine | 1 | 2022 | 995 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2023 | 1596 | 0.030 |
Why?
|
Ribonucleoproteins | 1 | 2016 | 359 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2885 | 0.030 |
Why?
|
Piperidines | 1 | 2022 | 1667 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1647 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2048 | 0.030 |
Why?
|
Child | 2 | 2011 | 80917 | 0.030 |
Why?
|
Adolescent | 2 | 2011 | 89169 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 22371 | 0.030 |
Why?
|
Leadership | 1 | 2021 | 1397 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6847 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2011 | 26422 | 0.020 |
Why?
|
Aging | 1 | 2009 | 8744 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2540 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3948 | 0.020 |
Why?
|
Prognosis | 1 | 2011 | 30010 | 0.020 |
Why?
|
Chromatin | 1 | 2021 | 2981 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2013 | 2179 | 0.020 |
Why?
|
Infant | 1 | 2011 | 36535 | 0.020 |
Why?
|
Salmo salar | 1 | 2008 | 7 | 0.020 |
Why?
|
Edwardsiella | 1 | 2008 | 6 | 0.020 |
Why?
|
Aeromonas hydrophila | 1 | 2008 | 9 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2009 | 752 | 0.020 |
Why?
|
Integrons | 1 | 2008 | 19 | 0.020 |
Why?
|
Water Pollutants, Chemical | 1 | 2012 | 359 | 0.020 |
Why?
|
Gene Order | 1 | 2008 | 166 | 0.020 |
Why?
|
Sequence Homology | 1 | 2008 | 197 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1183 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2025 | 65371 | 0.020 |
Why?
|
Erythrocyte Deformability | 1 | 2007 | 55 | 0.020 |
Why?
|
Signal Transduction | 1 | 2011 | 23645 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20760 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2474 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9263 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2011 | 1695 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2011 | 737 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2009 | 9561 | 0.020 |
Why?
|
Erythrocyte Membrane | 1 | 2007 | 438 | 0.020 |
Why?
|
Nucleotidyltransferases | 1 | 2008 | 242 | 0.020 |
Why?
|
Blood Group Antigens | 1 | 2007 | 183 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5703 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 22379 | 0.020 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2011 | 521 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1133 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2009 | 1528 | 0.010 |
Why?
|
Young Adult | 1 | 2011 | 60066 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2008 | 764 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4580 | 0.010 |
Why?
|
Glycine | 1 | 2007 | 672 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4413 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2011 | 1408 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2011 | 2709 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2016 | 4937 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2007 | 1497 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2008 | 1478 | 0.010 |
Why?
|
Cytoplasm | 1 | 2007 | 1505 | 0.010 |
Why?
|
Canada | 1 | 2008 | 2130 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13421 | 0.010 |
Why?
|
Exons | 1 | 2007 | 2394 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2008 | 1967 | 0.010 |
Why?
|
DNA Damage | 1 | 2011 | 2469 | 0.010 |
Why?
|
Cell Survival | 1 | 2011 | 5777 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14488 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17622 | 0.010 |
Why?
|
Protein Conformation | 1 | 2007 | 3956 | 0.010 |
Why?
|
Glucose | 1 | 2011 | 4352 | 0.010 |
Why?
|
Binding Sites | 1 | 2007 | 6020 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6514 | 0.010 |
Why?
|
Mitochondria | 1 | 2011 | 3681 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2008 | 4786 | 0.010 |
Why?
|
Insulin | 1 | 2011 | 6607 | 0.010 |
Why?
|
Escherichia coli | 1 | 2008 | 4214 | 0.010 |
Why?
|
Genotype | 1 | 2009 | 13045 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18412 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 21538 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5889 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10266 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18349 | 0.010 |
Why?
|